|
Delayed
Nasdaq
14:01:47 2026-08-26 EDT
|
5-day change | 1st Jan Change | ||
| 3.830 USD | -0.52% |
|
+17.48% | -29.96% |
| 08-11 | Bolt Biotherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 05-12 | Bolt Biotherapeutics reports first quarter 2026 financial results | RE |
Chart: Technical Analysis
Stock exchange
Nasdaq
BOLT 3.830 $
-0.52%
8.43K
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| BOLT | 3.830USD | -0.52% | 8.43K $ | |
CBOE
| 3.710USD | +11.75% | 7.81K $ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 4.05 | 4.05 | 4.42 |
| Spread/Res. | -5.43% | -5.43% | -13.35% |
| Spread/Supp. | +20.54% | +20.54% | +14.33% |
| Support | 3.177 | 3.177 | 3.35 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- BOLT Stock
- Charts Bolt Biotherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
